Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2026-04-18 @ 8:25 AM
Study NCT ID:
NCT05810350
Status:
UNKNOWN
Last Update Posted:
2023-04-13
First Post:
2023-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Aumolertinib Combined Intrathecal Chemotherapy for Leptomeningeal Metastasis From EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles
Sponsor:
Three Gorges Hospital of Chongqing University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2022(No.166)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None